03 December 2010 11,309 Be the first to comment
This content has been created by the Finextra editorial team with inputs from subject matter experts at the funding sponsor.
Tony Scianna of SunGard talks with Finextra about the future of OTC derivatives regulation on both sides of the Pond.
Welcome to Finextra. We use cookies to help us to deliver our services. You may change your preferences at our Cookie Centre.
Please read our Privacy Policy.